1. Trends in drug development costs, times, and risks;DiMasi;Drug Information Journal,1995
2. Joint United Nations Programme on HIV/AIDS, 2000. Report on the global HIV/AIDS epidemic. UNAIDS, Geneva, Switzerland, .
3. Prevalence of HIV infection in the United States, 1984–1992;Karon;Journal of the American Medical Association,1996
4. Lichtenberg, F.R., 2002. Pharmaceutical knowledge-capital accumulation and longevity, . In: Corrado, C., Haltiwanger, J., Sichel, D. (Eds.), Measuring Capital in the New Economy. University of Chicago Press, Chicago.
5. Changing patterns of mortality across Europe in patients infected with HIV-1;Mocroft;Lancet,1998